Alex Taylor of Inductive Bio has spoken about the use of artificial intelligence in drug discovery, according to AI Magazine. The interview was published by the outlet on Sunday, 1 November 2026.
AI Magazine describes the discussion as focused on how AI fits into the work of finding and developing new medicines. Taylor's remarks were presented under the headline "Inductive Bio's Alex Taylor on AI in Drug Discovery."
The interview adds to an ongoing public conversation about where artificial intelligence is being applied in pharmaceutical research. AI Magazine framed the discussion around drug discovery specifically, with Taylor representing Inductive Bio in the exchange.
The source material available does not include the full text of the interview, so the specific points Taylor made, any examples he cited, and any figures he referenced are not covered here.
What to watch next: the full interview at AI Magazine for Taylor's detailed views on AI's place in drug discovery.
